Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I
- PMID: 14612542
Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I
Abstract
Camptothecin (CPT) and its derivatives target mammalian DNA topoisomerase I (top1) and are among the most effective novel anticancer drugs. However, the activity of CPTs is limited by several factors, including drug inactivation by lactone ring opening, tumor drug resistance, and toxicity in patients. Novel top1 inhibitors are being searched to overcome such limitations and expand the anticancer spectrum of camptothecins. MJ-III-65 (NSC 706744) is among the most promising indenoisoquinolines to date. In this study, we show that MJ-III-65 enhances top1 cleavage complexes by both inhibiting their reversal (religation) more efficiently than CPT and by enhancing their formation. The top1 DNA cleavage complexes induced by MJ-III-65 exhibit a different distribution pattern compared with CPT and exhibit different base sequence preferences immediately around the top1 cleavage sites. Although CPTs have a preference for thymine at the (-1) position and guanine at the (+1) position of the top1-mediated DNA cleavage sites, MJ-III-65 can accommodate different base pairs at the (-1), (+1), or (+2) position, with a preference for a cytosine at the (-1) position on the scissile strand. Another difference with CPTs is the activity of MJ-III-65 against CPT-resistant top1 enzymes, implying that the amino acid residue interactions with top1 are different for MJ-III-65 and CPTs. As with CPT, MJ-III-65 is inactive against vaccinia top1. This study shows the specific molecular interactions of MJ-III-65 with top1 and demonstrates that MJ-III-65 is a potentially useful top1 inhibitor that enhances and traps top1 cleavage sites not sensitive to CPTs.
Similar articles
-
Cellular topoisomerase I inhibition and antiproliferative activity by MJ-III-65 (NSC 706744), an indenoisoquinoline topoisomerase I poison.Mol Pharmacol. 2005 Feb;67(2):523-30. doi: 10.1124/mol.104.003889. Epub 2004 Nov 5. Mol Pharmacol. 2005. PMID: 15531731
-
Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.J Med Chem. 1998 Jun 18;41(13):2216-26. doi: 10.1021/jm9605445. J Med Chem. 1998. PMID: 9632354
-
Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.Cancer Res. 2001 Mar 1;61(5):1964-9. Cancer Res. 2001. PMID: 11280753
-
Mechanisms of resistance to topoisomerase I-targeting drugs.Oncogene. 2003 Oct 20;22(47):7296-304. doi: 10.1038/sj.onc.1206935. Oncogene. 2003. PMID: 14576839 Review.
-
Camptothecins and topoisomerase I: a foot in the door. Targeting the genome beyond topoisomerase I with camptothecins and novel anticancer drugs: importance of DNA replication, repair and cell cycle checkpoints.Curr Med Chem Anticancer Agents. 2004 Sep;4(5):429-34. doi: 10.2174/1568011043352777. Curr Med Chem Anticancer Agents. 2004. PMID: 15379698 Review.
Cited by
-
Discovery of antitumor anthra[2,3-b]furan-3-carboxamides: Optimization of synthesis and evaluation of antitumor properties.Eur J Med Chem. 2016 Apr 13;112:114-129. doi: 10.1016/j.ejmech.2016.01.050. Epub 2016 Feb 4. Eur J Med Chem. 2016. PMID: 26890118 Free PMC article.
-
Discovery of potent indenoisoquinoline topoisomerase I poisons lacking the 3-nitro toxicophore.J Med Chem. 2015 May 14;58(9):3997-4015. doi: 10.1021/acs.jmedchem.5b00303. Epub 2015 Apr 24. J Med Chem. 2015. PMID: 25909279 Free PMC article.
-
Investigation of the Structure-Activity Relationships of Aza-A-Ring Indenoisoquinoline Topoisomerase I Poisons.J Med Chem. 2016 Apr 28;59(8):3840-53. doi: 10.1021/acs.jmedchem.6b00003. Epub 2016 Apr 12. J Med Chem. 2016. PMID: 27070999 Free PMC article.
-
Proteomic analysis of nuclei isolated from cancer cell lines treated with indenoisoquinoline NSC 724998, a novel topoisomerase I inhibitor.J Proteome Res. 2010 Aug 6;9(8):4016-27. doi: 10.1021/pr100194d. J Proteome Res. 2010. PMID: 20515076 Free PMC article.
-
A Facile method to transform trans-4-carboxy-3,4-dihydro-3-phenyl- 1(2H)-isoquinolones to indeno[1,2-c]isoquinolines.J Org Chem. 2005 Aug 5;70(16):6496-8. doi: 10.1021/jo050831t. J Org Chem. 2005. PMID: 16050715 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials